Abiopharma

Plus Therapeutics Secures National Coverage Agreement with Humana for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer

Sol-Gel Reports Third Quarter 2025 Financial Results and Provides Corporate Updates

Biogen to Highlight New Lecanemab Data and Scientific Advances at the 18th Clinical Trials on Alzheimer’s Disease Conference

Evogene Reports Third Quarter 2025 Financial Results

Ocugen CEO to Present at NobleCon21—Noble Capital Markets’ Twenty-First Annual Emerging Growth Equity Conference

Can-Fite’s CF602 Erectile Dysfunction Treatment Receives Notice of Patent Allowance in Brazil

Axsome Therapeutics to Participate in Upcoming Investor Conferences

Perspective Therapeutics to Participate in Upcoming December Conferences

Can-Fite’s CF602 Erectile Dysfunction Treatment Receives Notice of Patent Allowance in Brazil

Sagimet Biosciences to Participate in the 8th Annual Evercore ISI Healthcare Conference